We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.6B
AUM Growth
-$325M
Cap. Flow
-$723M
Cap. Flow %
-4.97%
Top 10 Hldgs %
7.37%
Holding
1,080
New
68
Increased
314
Reduced
422
Closed
79

Top Sells

Rank Stock Value
1
IMXI icon
International Money Express
IMXI
+$42M
2
OLN icon
Olin
OLN
+$40.2M
3
BC icon
Brunswick
BC
+$36.7M
4
AA icon
Alcoa
AA
+$33.9M
5
USCR
U S Concrete, Inc.
USCR
+$31.9M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 20.04%
3 Financials 15.03%
4 Consumer Discretionary 13.3%
5 Healthcare 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZPW icon
826
Ezcorp Inc
EZPW
$1.79B
$1.21M 0.01%
201,000
GMS
827
DELISTED
GMS Inc
GMS
$1.21M 0.01%
25,183
-902
-3% -$40K
ECHO
828
DELISTED
Echo Global Logistics, Inc.
ECHO
$1.21M 0.01%
39,329
-2,241
-5% -$73.9K
CENT icon
829
Central Garden & Pet Co
CENT
$2.76B
$1.18M 0.01%
27,868
-52,262
-65% -$2.34M
NGMS
830
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$1.17M 0.01%
19,000
-130,000
-87% -$6.79M
RNG icon
831
RingCentral
RNG
$4.83B
$1.16M 0.01%
4,000
TBLA icon
832
Taboola.com
TBLA
$1.41B
$1.16M 0.01%
+112,000
New +$1.16M
CVLG icon
833
Covenant Logistics
CVLG
$1.04B
$1.16M 0.01%
111,800
+5,800
+5% +$62.8K
CORT icon
834
Corcept Therapeutics
CORT
$9.98B
$1.15M 0.01%
52,173
-270
-0.5% -$6.01K
RADI
835
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$1.15M 0.01%
+79,192
New +$1.18M
INVA icon
836
Innoviva
INVA
$1.6B
$1.14M 0.01%
85,280
+2,837
+3% +$35.5K
CSGS
837
DELISTED
CSG Systems International
CSGS
$1.11M 0.01%
23,580
-45,106
-66% -$2.05M
AEL
838
DELISTED
American Equity Investment Life Holding Company
AEL
$1.11M 0.01%
34,422
+6,973
+25% +$220K
GBCI icon
839
Glacier Bancorp
GBCI
$6.36B
$1.11M 0.01%
20,196
-45,052
-69% -$2.64M
SNBR
840
DELISTED
Sleep Number
SNBR
$1.09M 0.01%
9,885
-879
-8% -$100K
LDL
841
DELISTED
Lydall, Inc.
LDL
$1.08M 0.01%
17,784
-783,323
-98% -$30.1M
MN
842
DELISTED
MANNING & NAPIER, INC.
MN
$1.07M 0.01%
136,600
CUBI icon
843
Customers Bancorp
CUBI
$2.66B
$1.07M 0.01%
27,442
+498
+2% +$17.9K
SCHW
844
Charles Schwab
SCHW
$182B
$1.07M 0.01%
14,671
AWR icon
845
American States Water
AWR
$3.44B
$1.05M 0.01%
13,200
+539
+4% +$42.9K
SXC icon
846
SunCoke Energy
SXC
$794M
$1.05M 0.01%
146,838
+7,479
+5% +$53.2K
CTSO icon
847
Cytosorbents Corp
CTSO
$22.2M
$1.03M 0.01%
137,000
ACVA icon
848
ACV Auctions
ACVA
$1.41B
$1.02M 0.01%
+40,000
New +$1.17M
HIBB
849
DELISTED
Hibbett, Inc. Common Stock
HIBB
$1.02M 0.01%
11,420
-1,712
-13% -$134K
PYPL icon
850
PayPal
PYPL
$49.9B
$1.01M 0.01%
3,466
-385
-10% -$102K

Similar funds

Royce & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Royce & Associates held 1,080 positions worth $14.6B, down 2.2% from $14.9B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Royce & Associates withdrew a net $723M in Q2 2021, closing 79 positions and reducing 422 holdings. Its most notable exit was Olin, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Organon & Co worth $16.5M.

  • Royce & Associates's largest Q2 2021 buy was Organon & Co: 546,803 shares worth $16.5M.
  • Royce & Associates added most to Vontier in Q2 2021, an estimated $50.7M increase.
  • Royce & Associates's biggest Q2 2021 reduction was International Money Express, cutting an estimated $42M.
  • Royce & Associates fully exited Olin in Q2 2021, selling an estimated $40.2M.
  • Royce & Associates's ten largest holdings make up 7.4% of its $14.6B portfolio in Q2 2021.
  • Royce & Associates opened 68 new positions and closed 79 in Q2 2021.
  • Royce & Associates's portfolio value fell 2.2% quarter-over-quarter to $14.6B.

Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.